NYC Injury Lawyers Say FDA Report Relating Bladder Cancer and Best-Selling Diabetes Drug Actos May H
New York personal injury lawyer Michael A. Rose of Hach & Rose says the FDA study confirming an increased risk of bladder cancer for diabetes patients who took Actos long-term can aid affected victims trying to document claims for compensation New York, NY (PRWEB) October 26, 2011 Michael A. Rose, partner at New York City personal injury law firm of Hach & Rose, LLP says the fact that the U.S. Food and Drug Administration (FDA) has issued a warning that the leading diabetes drug Actos (pioglitazone) may raise the risk of bladder cancer when used for more than a year can help victim
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Categories
- Articles 309
- Bankruptcy 44
- Business 134
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 57
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 608
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4